Suppr超能文献

印度北部一家转诊医院抗风湿药物使用情况的审计。

An audit of the use of antirheumatic drugs in a north Indian referral hospital.

作者信息

Balakrishnan S, Bambery P, Gupta N, Pandhi P

机构信息

Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Pharmacoepidemiol Drug Saf. 2001 May;10(3):237-43. doi: 10.1002/pds.591.

Abstract

OBJECTIVE

This study was conducted with the aim of auditing the pattern of use of antirheumatic drugs in a tertiary care hospital in Northern India.

METHODS

The study was carried out in 1000 patients recruited sequentially from the clinic for a period of 1 year (January to December 1999). Patient data such as age, sex, income, family size, diagnosis, duration of illness, drugs prescribed/duration, adverse drug reaction were noted and used to calculate core drug use indicators and pattern of drug use.

RESULTS

The pattern of drug use was in accordance with the standard practices followed internationally. In rheumatoid arthritis the most common prescriptions were for non-steroidal antiinflammatory drugs (NSAIDs) alone, followed by the combination of NSAIDs, disease modifying agents (DMARDs) and steroids. Of the NSAIDs diclofenac was the most frequently prescribed drug, while chloroquine was the most commonly used DMARD. The most commonly seen adverse drug reactions were gastritis, Cushings syndrome and decreased visual acuity.

CONCLUSION

In conclusion, this study has demonstrated that in this clinic, the pattern of use of antirheumatic drugs follows standard guidelines.

摘要

目的

本研究旨在审核印度北部一家三级护理医院抗风湿药物的使用模式。

方法

该研究对从诊所连续招募的1000名患者进行了为期1年(1999年1月至12月)的调查。记录患者的年龄、性别、收入、家庭规模、诊断、病程、所开药物/用药时长、药物不良反应等数据,并用于计算核心药物使用指标和药物使用模式。

结果

药物使用模式符合国际上遵循的标准做法。在类风湿性关节炎中,最常见的处方是单独使用非甾体抗炎药(NSAIDs),其次是NSAIDs、病情改善药物(DMARDs)和类固醇的联合使用。在NSAIDs中,双氯芬酸是最常开具的药物,而氯喹是最常用的DMARD。最常见的药物不良反应是胃炎、库欣综合征和视力下降。

结论

总之,本研究表明,在该诊所,抗风湿药物的使用模式遵循标准指南。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验